Market Access News | pharmaphorum

News

Acacia Pharma stock market launch to support nausea products

Acacia Pharma is to raise new funds through an initial global offering and launch on to the Euronext Brussels stock exchange

News

Novo Nordisk undeterred after losing out on Ablynx takeover

After losing out to Sanofi in its pursuit of Belgian biotech Ablynx earlier this week, Novo Nordisk has put a brave face on the disappointment.

News

New Vertex drugs could help 90% of cystic fibrosis patients

Vertex soars after news that tens of thousands of cystic fibrosis (CF) patients could benefit from treatment for the first time.

News

Tablets on dollar bills (treatment, addiction, aging - concept). Vintage effect.

Amazon, Buffet and JPMorgan healthcare plans send US insurer...

News that Amazon, Warren Buffett’s Berkshire Hathaway and JP Morgan are to join forces to launch a health plan for their US employees yesterday stopped the whole of healthcare in

News

NHS England plans to eliminate hep C by 2025 - with the help...

Health chiefs ask pharma to collaborate

News

NICE must be reformed - Janssen UK market access chief

Janssen’s UK pricing chief Jennifer Lee has called for reform of NICE following the company’s successful but drawn-out attempt to get its cancer drug Darzalex to NHS patients.

Acacia Pharma stock market launch to support nausea products

Novo Nordisk undeterred after losing out on Ablynx takeover

New Vertex drugs could help 90% of cystic fibrosis patients

Amazon, Buffet and JPMorgan healthcare plans send US insurer...

NHS England plans to eliminate hep C by 2025 - with the help...

NICE must be reformed - Janssen UK market access chief

Bankruptcy threat looms as Quince runs out of options

How to meet your physicians where they are online

News

Editor's Picks